share_log

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Timur

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Timur

4/A:持股變動聲明(修正)-高管 Dogan Timur
美股SEC公告 ·  2024/10/10 01:21

Moomoo AI 已提取核心訊息

Timur Dogan, Chief Technology Officer of Cardio Diagnostics Holdings, Inc. (CDIO), completed a purchase of 68,965 shares of common stock on September 6, 2024. The transaction was carried out on the open market at a price of $0.29 per share, resulting in a total investment of $19,999.85. Following this acquisition, Dogan's direct holdings in the company increased to 197,310 shares of common stock.
Timur Dogan, Chief Technology Officer of Cardio Diagnostics Holdings, Inc. (CDIO), completed a purchase of 68,965 shares of common stock on September 6, 2024. The transaction was carried out on the open market at a price of $0.29 per share, resulting in a total investment of $19,999.85. Following this acquisition, Dogan's direct holdings in the company increased to 197,310 shares of common stock.
Timur Dogan,心血管診斷控股有限公司(CDIO)的首席技術官,在2024年9月6日完成了購買68,965股普通股的交易。該交易在開放市場以每股0.29美元的價格進行,總投資額爲19,999.85美元。在此次收購之後,Dogan在公司的直接持股增加到了197,310股普通股。
Timur Dogan,心血管診斷控股有限公司(CDIO)的首席技術官,在2024年9月6日完成了購買68,965股普通股的交易。該交易在開放市場以每股0.29美元的價格進行,總投資額爲19,999.85美元。在此次收購之後,Dogan在公司的直接持股增加到了197,310股普通股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息